Can you provide the average price target for ARGAN INC stock?
10 analysts have analysed AGX and the average price target is 503.88 USD. This implies a price decrease of -17.75% is expected in the next year compared to the current price of 612.6.
NYSE:AGX • US04010E1091
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ARGAN INC (AGX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-27 | Lake Street | Maintains | Hold -> Hold |
| 2026-03-27 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2026-03-27 | Goldman Sachs | Maintains | Buy -> Buy |
| 2026-03-10 | Freedom Capital Markets | Initiate | Hold |
| 2025-12-05 | Lake Street | Downgrade | Buy -> Hold |
| 2025-12-01 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-11-10 | GLJ Research | Upgrade | Hold -> Buy |
| 2025-10-13 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-09-22 | GLJ Research | Initiate | Hold |
| 2025-09-05 | Lake Street | Maintains | Buy -> Buy |
| 2025-07-21 | JP Morgan | Initiate | Neutral |
| 2025-06-05 | Lake Street | Maintains | Buy -> Buy |
| 2025-03-28 | Lake Street | Upgrade | Hold -> Buy |
| 2024-12-06 | CJS Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-12-03 | Lake Street | Downgrade | Buy -> Hold |
| 2024-06-07 | Lake Street | Maintains | Buy -> Buy |
| 2024-04-12 | Lake Street | Maintains | Buy -> Buy |
| 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 573.333M 26.01% | 874.179M 52.47% | 944.606M 8.06% | 1.264B 33.81% | 1.529B 20.97% | 1.67B 9.22% | |
| EBITDA YoY % growth | 38.863M -14.40% | 90.1M 131.84% | 136.613M 51.62% | 201.58M 47.56% | 261.54M 29.75% | 300.86M 15.03% | |
| EBIT YoY % growth | 36.458M -12.57% | 88.195M 141.91% | 134.701M 52.73% | 159.33M 18.28% | 201.97M 26.76% | 192.1M -4.89% | |
| Operating Margin | 6.36% | 10.09% | 14.26% | 12.61% | 13.21% | 11.50% | |
| EPS YoY % growth | 2.39 1.27% | 6.11 155.65% | 9.74 59.41% | 11.07 13.65% | 14.52 31.17% | 16.80 15.73% |
All data in USD
| Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.25 40.90% | 2.55 1.97% | 2.88 32.84% | 3.38 -2.49% | 2.13 -5.47% | 2.44 -4.12% | 2.63 -8.90% | 2.99 -11.64% |
| Revenue Q2Q % growth | 258.59M 33.53% | 300.26M 26.30% | 330.61M 31.64% | 374.94M 43.08% | 284.11M 9.87% | 315.83M 5.19% | 330.57M -0.01% | 364.11M -2.89% |
| EBITDA Q2Q % growth | 40.124M 62.07% | 46.408M 49.89% | 54.683M 60.62% | 61.896M 24.83% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 35.2M 44.61% | 40.308M 34.11% | 45.969M 40.87% | 54.413M 14.14% | N/A | N/A | N/A | N/A |
All data in USD
10 analysts have analysed AGX and the average price target is 503.88 USD. This implies a price decrease of -17.75% is expected in the next year compared to the current price of 612.6.
ARGAN INC (AGX) will report earnings on 2026-06-02.
The consensus EPS estimate for the next earnings of ARGAN INC (AGX) is 2.25 USD and the consensus revenue estimate is 258.59M USD.
The number of analysts covering ARGAN INC (AGX) is 10.